| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2016) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC13 |
| UNII: | BTY153760O |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin 17A inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Psoriasis | 4 | D011565 | FDA |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Spondylitis, Ankylosing | 3 | D013167 | ClinicalTrials |
| Pityriasis Rubra Pilaris | 2 | D010916 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Pemphigoid, Bullous | 2 | D010391 | ClinicalTrials |
| Pyoderma | 2 | D011711 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1143503-69-8 |
| ChEMBL | CHEMBL1743034 |
| FDA SRS | BTY153760O |
| Guide to Pharmacology | 7541 |
CONTENTS